RALBP1 Antibody (Rabbit mAb) [G20F10]

CatNo: F7306

    Application: Reactivity:
    • Lane 1: MCF7, Lane 2: HT29, Lane 3: Hela
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    推奨WB希釈率: 1:10000

    使用情報

    Dilution
    1:10000 - 1:50000
    1:250 - 1:500
    1:10 - 1:1000
    Application
    WB, IHC, FCM
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    76 kDa 95 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール Human cerebral cortex tissue; Human placenta tissue; human skin tissue; HeLa cells; MDA-MB-231 cells; PC-3 cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:10000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
    IHC
    Experimental Protocol:
     
    Deparaffinization/Rehydration
    1. Deparaffinize/hydrate sections:
    2. Incubate sections in three washes of xylene for 5 min each.
    3. Incubate sections in two washes of 100% ethanol for 10 min each.
    4. Incubate sections in two washes of 95% ethanol for 10 min each.
    5. Wash sections two times in dH2O for 5 min each.
    6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
     
    Staining
    1. Wash sections in dH2O three times for 5 min each.
    2. Incubate sections in 3% hydrogen peroxide for 10 min.
    3. Wash sections in dH2O two times for 5 min each.
    4. Wash sections in wash buffer for 5 min.
    5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
    6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
    7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
    8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
    9. Wash sections three times with wash buffer for 5 min each.
    10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
    11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
    12. Immerse slides in dH2O.
    13. If desired, counterstain sections with hematoxylin.
    14. Wash sections in dH2O two times for 5 min each.
    15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
    16. Mount sections with coverslips and mounting medium.
     

    Datasheet & SDS

    生物学的記述

    Specificity
    RALBP1 Antibody (Rabbit mAb) [G20F10] detects endogenous levels of total RALBP1 protein.
    タンパク質の局在
    細胞膜、細胞質、細胞骨格、細胞内膜系、ミトコンドリア、細胞核
    Uniprot ID
    Q15311
    Clone
    G20F10
    Synonym(s)
    RLIP, RLIP1, RLIP76, RALBP1, RalA-binding protein 1, RalBP1, 76 kDa Ral-interacting protein, Dinitrophenyl S-glutathione ATPase, Ral-interacting protein 1, DNP-SG ATPase
    Background
    RalA binding protein 1 (RALBP1/RLIP76) is a multifunctional, ubiquitously expressed protein that serves both as a downstream effector of Ral and R‑Ras small GTPases and as an ATP‑dependent transporter for glutathione conjugates and xenobiotic toxins, integrating signaling, endocytosis and detoxification processes in proliferating and stressed cells. Structurally, RALBP1 contains domains that mediate binding to active, GTP‑loaded RALA and RALB and a region with GTPase‑activating protein activity toward CDC42 and RAC1, allowing it to inactivate these Rho family GTPases by stimulating their GTP hydrolysis and thereby modulate cytoskeletal reorganization and vesicle trafficking. As a Ral pathway effector, RALBP1 participates in receptor‑mediated endocytosis by regulating ligand‑dependent internalization of EGFR and insulin receptor and acts as a mitotic scaffold: during mitosis, it recruits cyclin B–CDK1 to EPSIN/EPN1 to block endocytosis, and to mitochondria via RALA to promote CDK1‑mediated phosphorylation and activation of dynamin‑related protein DNM1L, controlling mitochondrial fission during cell division. In parallel, RALBP1 functions as a primary ATP‑dependent transporter for glutathione conjugates of electrophilic lipid peroxidation products and a wide range of xenobiotics, including anthracyclines and vinca alkaloids, contributing to multidrug resistance by lowering intracellular concentrations of pro‑apoptotic oxidized lipids and chemotherapeutic agents. Overexpression of RALBP1 has been documented in multiple cancers, and in colorectal cancer, high RALBP1 protein levels correlate significantly with advanced UICC stage, nodal involvement, recurrence and death; multivariate analysis identifies RALBP1 overexpression as an independent predictor of shorter disease‑free and overall survival in stage‑stratified cohorts. Functional studies in tumor models show that depletion or inhibition of RALBP1 reduces migration and invasion, suppresses tumor growth and metastasis in prostate, bladder and colorectal cancer models, and in human lung and colon xenografts, antisense knockdown or inhibitory anti‑RALBP1 IgG alone induces rapid, complete and sustained tumor regression, while also enhancing the efficacy of cisplatin–vinorelbine chemotherapy. RALBP1 also mediateds transport of glutathione conjugates and xenobiotics and serves as a key effector function for cancer cell survival and chemoresistance, and RALBP1’s roles in Ral/Ras–Rho signaling, receptor endocytosis and mitotic mitochondrial dynamics couple upstream oncogenic pathways to changes in drug handling, oxidative stress tolerance and metastatic behavior.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください